DrugPatentWatch Database Preview
Profile for Taiwan Patent: I310384
US Patent Family Members and Approved Drugs for Taiwan Patent: I310384
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | May 23, 2022 | Pfizer Inc | XELJANZ XR | tofacitinib citrate |
➤ Sign Up | May 23, 2022 | Pf Prism Cv | XELJANZ | tofacitinib citrate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |